Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-17 · accession 0001784606-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-19 | 2024-01-17 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | F - Tax | $119.13 | -1,038 | 14.3K | -7% | -$123.7K | |
| 2024-01-19 | 2024-01-17 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | A - Grant | $0.00 | +2,210 | 15.4K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-01-17 | F | D | 1,038 | $119.13 | 14,331 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-01-17 | A | A | 2,210 | $0.00 | 15,369 | D | — | — |